Kentera

Medicinal product

(Invented) name

Kentera

Active substance (s)

Oksibutininas

Strength

3,9 mg/24 val

Pharmaceutical form

transderminis pleistras

Route (s) of administration

vartoti ant odos

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BD04, Oxybutynin

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2004-06-15

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Transdermal patch	1 vnt.
Oksibutininas	3,9 mg/24 val

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
26306	28885	1028885	paketėlis	N8		Receptinis	EU/1/03/270/001	Netiekiama	-	-	No	-	-
26307	28886	1028886	paketėlis	N24		Receptinis	EU/1/03/270/002	Netiekiama	-	-	No	-	-
26308	28887	1028887	paketėlis	N2		Receptinis	EU/1/03/270/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2004-06-15	Registruotas